NANJING, China I May 31, 2025 I Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") today announced the presentation of groundbreaking clinical data from a ...

Enantiomers, or molecule pairs that are mirror images of each other, make up more than half of FDA-approved drugs in use ...

“We are not sending any GPU designs to China to be modified to comply with export controls,” a spokesperson said in a statement to CNBC. The Financial Times was the first to report the ...

ACADIA Pharmaceuticals stock jumped 26.4% Friday afternoon. Shares gained following a favorable court ruling. Get stock picks, daily rankings, and pro-level trading tools in one powerful platform ...

Acadia Pharmaceuticals (NASDAQ:ACAD) soared 28% after a court ruling in patent suit regarding its drug Nuplazid, which is used to treat Parkinson's disease. The court ruled that Aurobindo Pharma ...

BioMarin Pharmaceutical has agreed to acquire Inozyme Pharma for $4 ashare, or about $270 million in cash. The companies said Friday that their tie-up would strengthen BioMarin's enzyme therapies ...

Microsoft has continued to design, manufacture, and sell new Surface hardware since longtime team leader Panos Panay left the company for Amazon in late 2023, including both Intel- and Qualcomm ...

The initial public offerings (IPOs) of Integrity Infrabuild Developers and Accretion Pharmaceuticals were fully subscribed on May 14. The IPO of Integrity Infrabuild Developers will close on May ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

GSK GSK2.07%increase; green up pointing triangle will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 billion as it seeks to boost its pipeline of new drugs. The British ...

SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and ...